| Primary |
| Ill-defined Disorder |
26.7% |
| Hodgkin's Disease |
22.4% |
| Product Used For Unknown Indication |
15.5% |
| Drug Exposure During Pregnancy |
6.9% |
| Menorrhagia |
6.9% |
| Epilepsy |
4.3% |
| Acute Myeloid Leukaemia |
3.4% |
| Contraception |
3.4% |
| Drug Use For Unknown Indication |
2.6% |
| Menstrual Disorder |
2.6% |
| Lupus Nephritis |
1.7% |
| Dysmenorrhoea |
0.9% |
| Haemorrhage |
0.9% |
| Hypertension |
0.9% |
| Oligomenorrhoea |
0.9% |
|
| Cerebral Venous Thrombosis |
18.2% |
| Pruritus |
18.2% |
| Paraesthesia |
13.6% |
| Weight Decreased |
9.1% |
| Face Oedema |
4.5% |
| Haemorrhage |
4.5% |
| Off Label Use |
4.5% |
| Palpitations |
4.5% |
| Platelet Count Increased |
4.5% |
| Premature Labour |
4.5% |
| Pulmonary Embolism |
4.5% |
| Stupor |
4.5% |
| Ventricular Septal Defect |
4.5% |
|
| Secondary |
| Product Used For Unknown Indication |
60.3% |
| Pain |
6.9% |
| Myelodysplastic Syndrome |
6.3% |
| Acute Myeloid Leukaemia |
5.2% |
| Epilepsy |
5.2% |
| Gastrooesophageal Reflux Prophylaxis |
1.7% |
| Hormone Replacement Therapy |
1.7% |
| Idiopathic Thrombocytopenic Purpura |
1.7% |
| Antiemetic Supportive Care |
1.4% |
| Haematology Test Abnormal |
1.4% |
| Menorrhagia |
1.3% |
| Back Pain |
1.1% |
| Contraception |
1.1% |
| Drug Exposure During Pregnancy |
1.1% |
| Ewing's Sarcoma |
1.1% |
| Nausea |
0.8% |
| Prophylaxis |
0.6% |
| Drug Use For Unknown Indication |
0.5% |
| Haemorrhage |
0.5% |
| Ankylosing Spondylitis |
0.3% |
|
| Venoocclusive Liver Disease |
27.6% |
| Ventricular Septal Defect |
21.3% |
| Premature Labour |
13.4% |
| Platelet Count Increased |
6.3% |
| Breast Cancer |
3.1% |
| Dilatation Intrahepatic Duct Acquired |
3.1% |
| Haemoglobin Decreased |
2.4% |
| Haemorrhage |
2.4% |
| Live Birth |
2.4% |
| Venoocclusive Disease |
2.4% |
| Weight Decreased |
2.4% |
| Alanine Aminotransferase Increased |
1.6% |
| Breast Cancer Metastatic |
1.6% |
| Drug Exposure During Pregnancy |
1.6% |
| Melaena |
1.6% |
| Pregnancy On Oral Contraceptive |
1.6% |
| Pruritus |
1.6% |
| Rectal Haemorrhage |
1.6% |
| Vaginal Haemorrhage |
1.6% |
| Blood Alkaline Phosphatase Increased |
0.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
15.5% |
| Prophylaxis Of Nausea And Vomiting |
10.1% |
| Drug Use For Unknown Indication |
8.1% |
| Prophylaxis |
6.4% |
| Acute Myeloid Leukaemia |
6.2% |
| Hypogonadism |
5.4% |
| Depression |
4.9% |
| Follicle-stimulating Hormone Deficiency |
4.9% |
| Ovarian Disorder |
4.9% |
| Epilepsy |
3.9% |
| Luteinising Hormone Deficiency |
3.9% |
| Pain |
3.7% |
| Crohn's Disease |
3.4% |
| Dysmenorrhoea |
3.0% |
| Hypertension |
3.0% |
| Myelodysplastic Syndrome |
3.0% |
| Antiemetic Supportive Care |
2.5% |
| Haematology Test Abnormal |
2.5% |
| Thyroid Disorder |
2.5% |
| Analgesic Therapy |
2.2% |
|
| Weight Decreased |
14.3% |
| Vomiting |
9.5% |
| Unresponsive To Stimuli |
7.9% |
| Nasopharyngitis |
6.3% |
| Menorrhagia |
4.8% |
| Migraine |
4.8% |
| Neutropenia |
4.8% |
| Pancreatic Disorder |
4.8% |
| Premature Rupture Of Membranes |
4.8% |
| Suicidal Ideation |
4.8% |
| Thrombocytopenia |
4.8% |
| Burning Sensation |
3.2% |
| Death |
3.2% |
| Haemorrhage |
3.2% |
| Hypokalaemia |
3.2% |
| Hysterectomy |
3.2% |
| Infection |
3.2% |
| Nausea |
3.2% |
| Osteopenia |
3.2% |
| Pain |
3.2% |
|
| Interacting |
| Epilepsy |
33.3% |
| Menstrual Disorder |
33.3% |
| Ankylosing Spondylitis |
22.2% |
| Menorrhagia |
11.1% |
|
| Pruritus |
40.0% |
| Liver Disorder |
20.0% |
| Liver Function Test Abnormal |
20.0% |
| Photopsia |
20.0% |
|
